Literature DB >> 1097523

Antigenic competition between two sequentially acting antigens. Immunosuppressive effect of T cells in spleen and lymph nodes of mouse.

J C Monier.   

Abstract

This study concerns the antigenic competition among heterologous red cells, a T suppressor-dependent phenomenon, in three cases, when the two antigens are administered by various routes, in (a) splenectomized mice or in Nude mice reconstituted with (b) lymph node cells, or spleen cells. Competition occurs whatever the routes of antigenic introduction, except when the two antigens are injected subcutaneously in the same leg and the anti-SRC plaque-forming cells are counted in the draining lymph nodes. In that case, the first antigen plays the role of adjuvant to the second. An adjuvant effect is also observed in splenectomized mice when the antigens are introduced intraperitoneally. However, competition does not occur in Nude mice but is present when those animals have been reconstituted either with lymphnode cells or with spleen cells. Those results play in favor of the presence of T suppressors, both in lymph nodes and in spleen; however, in lymph nodes, the immunosuppressive action induced by the first antigen is exceeded by an concomitant adjuvant effect.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1097523

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  3 in total

1.  Suppression of T-cell responses to histocompatibility antigens by BCG pre-treatment.

Authors:  S Orbach-Arbouys; M Castes
Journal:  Immunology       Date:  1980-02       Impact factor: 7.397

2.  Antigenic competition in the induction of contact sensitivity in mice.

Authors:  Y Nakano
Journal:  Immunology       Date:  1977-08       Impact factor: 7.397

3.  In vivo and in vitro responses to sheep erythrocytes by lymph node cells from mice with trichinellosis.

Authors:  J F Jones; C A Crandall; R B Crandall
Journal:  Clin Exp Immunol       Date:  1984-08       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.